scholarly journals Incidence and predictive factors of spinal cord stimulation treatment after lumbar spine surgery

2017 ◽  
Vol Volume 10 ◽  
pp. 2405-2411 ◽  
Author(s):  
Merja Vakkala ◽  
Voitto Järvimäki ◽  
Hannu Kautiainen ◽  
Maija Haanpää ◽  
Seppo Alahuhta
Keyword(s):  
Spinal Cord ◽  
Lumbar Spine ◽  
Spine Surgery ◽  
Predictive Factors ◽  
Spinal Cord Stimulation ◽  
Lumbar Spine Surgery

60. Spine patients demystified: what are the predictive factors of poor surgical outcomes in patients after elective lumbar spine surgery?

2019 ◽  
Vol 19 (9) ◽  
pp. S30
Author(s):  
Jose H. Jimenez-Almonte ◽  
Ifeanyi N. Nzegwu ◽  
Boshen Liu ◽  
Zeeshan Akhtar ◽  
Jonathan D. Grabau ◽  
...  
Keyword(s):  
Lumbar Spine ◽  
Spine Surgery ◽  
Predictive Factors ◽  
Surgical Outcomes ◽  
Lumbar Spine Surgery

scholarly journals Predictive Factors for Dural Tear in Lumbar Spine Surgery

2015 ◽  
Vol 13 (1) ◽  
pp. 35-40
Author(s):  
Abdelaal Abdelbaky ◽  
Walid Younes ◽  
Mohammed Adawi
Keyword(s):  
Lumbar Spine ◽  
Spine Surgery ◽  
Predictive Factors ◽  
Lumbar Spine Surgery ◽  
Dural Tear

Spine patients demystified: what are the predictive factors of poor surgical outcome in patients after elective cervical and lumbar spine surgery?

2020 ◽  
Vol 20 (10) ◽  
pp. 1529-1534
Author(s):  
José H. Jiménez-Almonte ◽  
Gavin S. Hautala ◽  
Eric J. Abbenhaus ◽  
Jonathan D. Grabau ◽  
Ifeanyi N. Nzegwu ◽  
...  
Keyword(s):  
Lumbar Spine ◽  
Spine Surgery ◽  
Predictive Factors ◽  
Surgical Outcome ◽  
Lumbar Spine Surgery

scholarly journals 329 Prolonged Use of Narcotic Following Lumbar Spine Surgery: Predictive Factors and Outcome Analysis

Neurosurgery ◽  
2018 ◽  
Vol 65 (CN_suppl_1) ◽  
pp. 132-132
Author(s):  
Lee Onn Chieng ◽  
Karthik Madhavan ◽  
Nahom T Teferi ◽  
Michael Y Wang ◽  
Steven Vanni
Keyword(s):  
Lumbar Spine ◽  
Spine Surgery ◽  
Predictive Factors ◽  
Outcome Analysis ◽  
Lumbar Spine Surgery

Double-blind, randomized controlled trial of tranexamic acid in minor lumbar spine surgery: no effect on operative time, intraoperative blood loss, or complications

2019 ◽  
Vol 31 (2) ◽  
pp. 194-200 ◽  
Author(s):  
Signe Elmose ◽  
Mikkel Ø. Andersen ◽  
Else Bay Andresen ◽  
Leah Yacat Carreon
Keyword(s):  
Placebo Group ◽  
Lumbar Spine ◽  
Blood Loss ◽  
Tranexamic Acid ◽  
Spine Surgery ◽  
Operative Time ◽  
Decompressive Surgery ◽  
Lumbar Spine Surgery ◽  
Intraoperative Blood Loss ◽  
Double Blind

OBJECTIVEThe purpose of this study was to investigate the effect of tranexamic acid (TXA) compared to placebo in low-risk adult patients undergoing elective minor lumbar spine surgery—specifically with respect to operative time, estimated blood loss, and complications. Studies have shown that TXA reduces blood loss during major spine surgery. There have been no previous studies on the effect of TXA in minor lumbar spine surgery in which these variables have been evaluated.METHODSThe authors enrolled patients with ASA grades 1 to 2 scheduled to undergo lumbar decompressive surgery at Middelfart Hospital into a double-blind, randomized, placebo-controlled, parallel-group study. Patients with thromboembolic disease, coagulopathy, hypersensitivity to TXA, or a history of convulsion were excluded. Patients were randomly assigned, in blocks of 10, to one of 2 groups, TXA or placebo. Anticoagulation therapy was discontinued 2–7 days preoperatively. Prior to the incision, patients received either a bolus of TXA (10 mg/kg) or an equivalent volume of saline solution (placebo). Independent t-tests were used to compare differences between the 2 groups, with statistical significance set at p < 0.05.RESULTSOf the 250 patients enrolled, 17 patients were excluded, leaving 233 cases for analysis (117 in the TXA group and 116 in the placebo group). The demographics of the 2 groups were similar, except for a higher proportion of women in the TXA group (TXA 50% vs placebo 32%, p = 0.017). There was no significant between-groups difference in operative time (49.53 ± 18.26 vs 54.74 ± 24.49 minutes for TXA and placebo, respectively; p = 0.108) or intraoperative blood loss (55.87 ± 48.48 vs 69.14 ± 83.47 ml for TXA and placebo, respectively; p = 0.702). Postoperative blood loss measured from drain output was 62% significantly lower in the TXA group (13.03 ± 21.82 ml) than in the placebo group (34.61 ± 44.38 ml) (p < 0.001). There was no significant difference in number of dural lesions or postoperative spinal epidural hematomas, and there were no thromboembolic events.CONCLUSIONSTranexamic acid did not have a statistically significant effect on operative time, intraoperative blood loss, or complications. This study gives no evidence to support the routine use of TXA during minor lumbar decompressive surgery.Clinical trial registration no.: NCT03714360 (clinicaltrials.gov)

Sign in / Sign up

Export Citation Format

Share Document